PRLX Financials Monday, July 14, 2014 11:09:54 PM

PRLX Financials Monday, July 14, 2014 11:09:54 PM
Parallax Health Sciences Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - 20
Cost of Revenue - - - 36
Gross Profit - - - (16)
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 473 483 409 1,063
Non-Recurring Items - - - -
Other - - - -
Operating Income (473) (483) (409) (1,078)
Income From Continuing Operations
Add'l Income/Expense Items (11) (61) (251) (3,292)
Earnings Before Interest and Tax (484) (543) (660) (1,078)
Interest Expense 21 11 - 759
Earnings Before Tax (504) (555) (660) (1,838)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (504) (555) (660) (5,130)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (504) (555) (660) (5,130)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (504) (555) (660) (5,130)